Multiplex Biomarker Imaging Market report contains detailed information on factors influencing demand, growth, opportunities, challenges, and restraints. It provides detailed information about the ...

Opportunities in the Middle East imaging biomarkers market include the expansion of advanced imaging infrastructure and increased adoption of biomarker-driven clinical pathways. Driven by rising ...

Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...

The NASH Biomarkers Market sees major opportunities in non-invasive diagnostics combining serum markers, imaging, and AI for metabolic disease management. Key growth drivers include the demand for ...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) announces today it has signed an initial ...

Despite the widespread acceptance of RECIST v1.1, its use to assess efficacy on the basis of simple measurements of tumor size on conventional anatomic imaging methods (such as computed tomography [CT ...

• Applications of germline genetic testing, tumor genomics, and other biomarkers are now routinely used in risk assessment, determination of treatment course, prognosis, and monitoring. • Imaging ...

Please provide your email address to receive an email when new articles are posted on . A neurotech company has announced an agreement with a radiopharmaceutical firm for the rights to manufacture an ...

The SPEAR UltraDetect ™ pTau 217 biomarker assay kit is a specialized tool for researching Alzheimer’s disease (AD) using plasma samples. The assay requires the SPEAR UltraDet ...

Using a deep learning AI model, researchers identified the first-of-its-kind biomarker of chronic stress detectable through routine imaging, according to research presented at the annual meeting of ...